Cargando…

Intravenous magnesium reduces infarct size following an ischaemia/reperfusion injury combined with a thrombogenic lesion in the LAD

Detalles Bibliográficos
Autores principales:	Ravn, HB, Ilkjaer, LB, Moeldrup, U, Jensen, L, Chew, M, Johnsen, S, Birk-Soerensen, L, Tønnesen, E, Hjortdal, VE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1998
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301296/ http://dx.doi.org/10.1186/cc184

Ejemplares similares

A new model for evaluation of thrombosis and ischaemia/reperfusion injury
por: Ravn, HB, et al.
Publicado: (1998)

Is intravenous lidocaine protective against myocardial ischaemia and reperfusion injury after cardiac surgery?
por: Zhang, Chengyuan, et al.
Publicado: (2020)

Complement in ischaemia–reperfusion injury and transplantation
por: Howard, Mark C., et al.
Publicado: (2021)

Comment on: Dual LAD with anomalous origin of long LAD from right coronary sinus: A variant of type VI LAD
por: Prasad, Abhishek, et al.
Publicado: (2017)

A Shropshire lad
por: Housman, A. E. (Alfred Edward), 1859-1936
Publicado: (1950)

A Keen Lad
Publicado: (1909)

Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity
por: Chiu, Wei Che, et al.
Publicado: (2019)

Correction to: Complement in ischaemia–reperfusion injury and transplantation
por: Howard, Mark C., et al.
Publicado: (2022)

Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury
por: Martin, Jack L., et al.
Publicado: (2018)

Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury
por: Baidya, Raji, et al.
Publicado: (2020)

Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned
por: Silvis, Max J. M., et al.
Publicado: (2021)

Types of Dual LAD—Nomenclature confusion!!!
por: Rao, M. Sudhakar
Publicado: (2018)

l‐Fucose prevention of renal ischaemia/reperfusion injury in Mice
por: Howard, Mark C., et al.
Publicado: (2019)

Nanomedicine for the reduction of the thrombogenicity of stent coatings
por: Karagkiozaki, Varvara C, et al.
Publicado: (2010)

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation
por: Berezin, Alexander E., et al.
Publicado: (2022)

Tumor Genetics Are Thrombogenic: The Need for Action
por: Mahé, Isabelle, et al.
Publicado: (2023)

The cardioprotective potential of valsartan in myocardial ischaemia reperfusion injury
por: Hadi, Najah R., et al.
Publicado: (2015)

Corticomedullary shunting after ischaemia and reperfusion in the porcine kidney?
por: Rehling, Michael, et al.
Publicado: (2022)

The effects of ischaemic conditioning on lung ischaemia–reperfusion injury
por: Vlastos, Dimitrios, et al.
Publicado: (2022)

Ischaemia–reperfusion injury impairs tissue plasminogen activator release in man
por: Pedersen, Christian M., et al.
Publicado: (2012)

Tomographic Findings and Thrombogenic Effects of COVID-19
por: Mourão, Rodrigo, et al.
Publicado: (2020)

Targeting thrombogenicity and inflammation in chronic HIV infection
por: O’Brien, Meagan P., et al.
Publicado: (2019)

Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices
por: Labarrere, Carlos A., et al.
Publicado: (2020)

Rapid predictors for the occurrence of reduced left ventricular ejection fraction between LAD and non-LAD related ST-elevation myocardial infarction
por: Chen, Zhang-Wei, et al.
Publicado: (2016)

Reversible Pulmonary Hypertension due to Combined Fistula between the Left Anterior Descending Artery (LAD) and Pulmonary Artery and Severe Stenosis of the LAD
por: Schizas, N., et al.
Publicado: (2021)

Comparison of angiographic results and clinical outcomes of no-reflow after stenting in left anterior descending (LAD) versus non-LAD culprit STEMI
por: Khan, Kamran Ahmed, et al.
Publicado: (2022)

Machine perfusion of the liver: Which is the best technique to mitigate ischaemia-reperfusion injury?
por: Boteon, Yuri L, et al.
Publicado: (2019)

Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours
por: Korbelik, M, et al.
Publicado: (2003)

Effect of pomiferin administration on kidney ischaemia-reperfusion injury in rats
por: Bartošíková, Lenka, et al.
Publicado: (2010)

Pathophysiology of early ischaemia reperfusion injury of the colon in aortic surgery
por: Khwaja, N, et al.
Publicado: (2004)

Which pathways trigger the role of complement in ischaemia/reperfusion injury?
por: Farrar, Conrad A., et al.
Publicado: (2012)

Systemic inflammation affects reperfusion following transient cerebral ischaemia
por: Burrows, F., et al.
Publicado: (2016)

Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury
por: Maneechote, Chayodom, et al.
Publicado: (2017)

Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction
por: Situmorang, Gerhard R., et al.
Publicado: (2018)

Klotho protein contributes to cardioprotection during ischaemia/reperfusion injury
por: Olejnik, Agnieszka, et al.
Publicado: (2020)

The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium
por: Shah, Mohammed, et al.
Publicado: (2020)

Inhibition of adenosine kinase attenuates myocardial ischaemia/reperfusion injury
por: Wang, Wenjun, et al.
Publicado: (2021)

How Machine Perfusion Ameliorates Hepatic Ischaemia Reperfusion Injury
por: Clarke, George, et al.
Publicado: (2021)

Extracellular histones are a target in myocardial ischaemia–reperfusion injury
por: Shah, Mohammed, et al.
Publicado: (2021)

Alterations in mitochondrial protein glycosylation in myocardial ischaemia reperfusion injury
por: Feng, Xinyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hd6nnkf1j99biq1t5j6kbqa8od